abstract |
The present invention relates to the use of 2-substituted pyridines of the formula (I) and the pharmaceutically acceptable salts of the 2-substituted pyridines of formula I in therapy, in particular in therapy or treatment of cancerous diseases. in which the indices and the substituents are as definedin the claims and the specification. |